Pharma channel feed

Al­mac com­mits to $65M ex­pan­sion for its Penn­syl­va­nia HQ amid wider in­vest­ments

3 years ago
Financing
Manufacturing

CSL CEO Paul Per­reault de­ter­mined to grow plas­ma col­lec­tion af­ter full-year sales dip

3 years ago

Bay­er aims to sim­pli­fy the com­plex­i­ties of CKD with an ABC-themed ad cam­paign

3 years ago
Marketing

En­do files for Chap­ter 11 as it looks to fin­ish off its opi­oid lit­i­ga­tion

3 years ago
Law

Mod­er­na taps new CFO from PerkinElmer af­ter for­mer one-day CFO oust­ed

3 years ago
People

WuXi STA breaks ground on Delaware fa­cil­i­ty, boost­ing its US pres­ence

3 years ago
Manufacturing

So­lo Jonas broth­er car­ries Merz's new tune in Botox ri­val cam­paign

3 years ago

Gen­mab launch­es cor­po­rate cam­paign am­pli­fy­ing its ‘knock your socks off’ an­ti­bod­ies

3 years ago
Marketing

Pres­i­dent Biden signs ma­jor drug pric­ing re­forms in­to law: What's com­ing for bio­phar­ma?

3 years ago
Law

Ab­b­Vie calls off PhI tri­al for I-Mab’s CD47 days af­ter Zai Lab shelves its own pro­gram

3 years ago
R&D

Bris­tol My­ers gets nec­es­sary clear­ance for $4.1B Turn­ing Point ac­qui­si­tion

3 years ago
Deals
R&D

Bill & Melin­da Gates Foun­da­tion dou­bles down on health part­ner­ship with South Ko­rea — re­port

3 years ago

HHS in­spec­tor gen­er­al: NIH failed to ver­i­fy clin­i­cal tri­al re­sults were re­port­ed on time

3 years ago
FDA+

More than a decade af­ter its ac­cel­er­at­ed ap­proval, vot­ing ques­tions set for pre­ma­ture birth drug's with­draw­al hear­ing

3 years ago
FDA+

As­traZeneca files law­suit against for­mer ex­ec as he jumps to GSK

3 years ago
People
Law

What’s in mon­key­pox names? His­to­ry, tra­di­tion­al con­ven­tion and even sit­com sug­ges­tions

3 years ago
Marketing

Mar­ket­ingRx roundup: Ho­log­ic taps fa­mous singer again for women’s health screens; HIV drug mak­ers pitch in to raise aware­ness for mon­key­pox

3 years ago
Marketing

FDA grants pri­or­i­ty re­view to Lyn­parza com­bo ther­a­py for metasta­t­ic prostate can­cer

3 years ago
R&D
FDA+

Roche’s Po­livy con­tin­ues its reg­u­la­to­ry dance, will head to FDA for a form of blood can­cer

3 years ago
R&D

UK says it won't pur­chase As­traZeneca's Covid treat­ment due to 'in­suf­fi­cien­t' Omi­cron da­ta — re­ports

3 years ago
Coronavirus

Gilead­'s Trodelvy scores 'sur­prise' OS win in metasta­t­ic breast can­cer, but da­ta will wait for an up­com­ing con­fer­ence

3 years ago

Mod­er­na's bi­va­lent Omi­cron vac­cine se­cures reg­u­la­to­ry OK in UK

3 years ago
Coronavirus

Emer­gent nets it­self more trou­ble as it re­ceives a warn­ing let­ter from the FDA

3 years ago
FDA+
Manufacturing

French phar­ma ex­ec says he lied to FDA in at­tempt to steal a No­var­tis weight loss drug

3 years ago
Law
First page Previous page 179180181182183184185 Next page Last page
A service from the Financial Times